In rural America, where rheumatology offices are fewer and farther between, the expansion of telemedicine has been a boon during the COVID-19 pandemic. However, lab closures and reduced hospital services have made monitoring patients’ medications more challenging.
![](https://www.the-rheumatologist.org/wp-content/uploads/2020/03/GettyImages_Coronavirus_500x250-150x150.jpg)